how dangerous is tirzepatide vs. Semaglutide: Which Better For You ? New report reveals illegal ingredients

The GIP component adds metabolic benefits that amplify the appetite suppression and blood sugar regulation that GLP-1 provides alone

In the SURMOUNT trials for obesity, gastrointestinal adverse events increased with dose: 39% at 5 mg, 46% at 10 mg, and 49% at the 15 mg dose

The gastrointestinal tract slows down naturally during nighttime hours

Not every patient who develops gastroparesis or vision loss while taking a GLP-1 drug is informed by their physician of the potential link at the time of diagnosis

Hypersensitivity Reactions: Anaphylaxis or angioedema has been reported in clinical trials

Needle length for the thigh The goal is reaching the subcutaneous layer without going through it into muscle